Dr. Reddys Laboratories informs about company updates

23 Aug 2018 Evaluate

Further to the intimation dated June 2, 2018 with regard to the audit of the API Srikakulam Plant (SEZ), Andhra Pradesh, Dr. Reddys Laboratories has informed that the Company has received an Establishment Inspection Report (EIR) from the US FDA, for the above-referred facility, indicating closure of the audit.

The above information is a part of company’s filings submitted to BSE.

 

Dr. Reddys Lab Share Price

5901.95 -16.60 (-0.28%)
14-May-2024 13:23 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1531.40
Dr. Reddys Lab 5901.95
Cipla 1374.20
Zydus Lifesciences 990.90
Lupin 1643.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.